DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/7cpgvf/terumo_medical) has announced the addition of the "Terumo Medical Device Company Intelligence Report" company profile to their offering.
Since its formation in 1921 as a manufacturer of thermometers, Japan-based Terumo has evolved into a global medical device company that has grown in recent years through various business collaborations and strategic mergers and acquisitions.
Since deciding to embark on a course of full-fledged overseas expansion in 1999, Terumo has completed several strategic acquisitions to augment its operations in the medical field. This began with the purchase of US-based 3M's cardiovascular business unit in 1999; followed by UK-based Vascutek, a manufacturer of vascular grafts, in 2002; Mission Medical, located in the US, to start up a company that develops automated blood collection devices, in 2005; US-based MicroVention, which manufactures and markets coils for the treatment of cerebral aneurysms in 2006; the tissue heart valve business of Kohler Chemie of Germany in March 2007; and the acquisition of CaridianBCT from Gambro to boost its blood business in 2011.
Today, the company's products are sold in over 160 countries worldwide and are provided through four business segments:
- Disposable medical devices and medical electronics, including syringes, needles, blood collection tubes, solution sets, IV catheters, infusion pumps, syringe pumps, home parenteral nutrition systems and home oxygen therapy systems.
- Pharmaceuticals, including IV solutions, nutritional food, prefilled syringes and continuous ambulatory peritoneal dialysis (CAPD) systems.
- Diabetes care, including blood glucose monitoring systems.
Cardiac and Vascular
- Interventional systems, including angiographic catheters, percutaneous transluminal coronary angioplasty (PTCA) balloon catheters, coronary stents and neuro interventional coils.
- Cardiovascular systems, including oxygenators, cardiopulmonary bypass systems and a left ventricular assist (LVA) system.
- Vascular grafts, including artificial vascular and stent grafts.
- Blood bags and automated blood processing devices.
- Digital thermometers, blood pressure monitors and over-the-counter (OTC) blood glucose monitors.
Terumo operates in more than 80 locations worldwide. Its principal subsidiaries include US-based Terumo Medical, Terumo Cardiovascular Systems (Terumo CVS), TerumoBCT, Harvest Technologies, Terumo Heart and MicroVention, Terumo Europe in Belgium and the UK, Terumo Penpol in India and Vascutek in the UK.
In the year ended 31st March 2012, Terumo generated net income of ¥24.2 billion on net sales of ¥386.7.0 billion. The company has approximately 18,112 employees worldwide.
As of the end of March 2012, trust and banking companies held a combined 26.8 per cent of Terumo's issued shares. Olympus Corporation, whose Medical Systems division is a leading manufacturer of gastro-intestinal and surgical endoscopes, endotherapy devices, endoscopic ultrasound systems and related products, owned 2.5 per cent of Terumo.
This Medical Device Company Intelligence Report provides a full review of the company's activities, from its origins to its latest corporate activity, including mergers and acquisitions, agreements, divestitures, major purchasing contracts and litigation. Sections are included on products, international activities and R&D, as well as a full, in-depth five year financial analysis.
Key Topics At A Glance
- Strategic Focus
- Research And Development
- Mergers And Acquisitions
- Minority Investments
- Joint Ventures
- Key Corporate Events
For more information visit http://www.researchandmarkets.com/research/7cpgvf/terumo_medical